CTVA - Corteva, Inc.
| Previous Close | 27.82 |
| Open | 27.82 |
| Bid | 27.91 x 900 |
| Ask | 27.92 x 900 |
| Day's Range | 27.50 - 28.05 |
| 52 Week Range | 24.10 - 32.78 |
| Volume | 2,707,446 |
| Avg. Volume | 6,386,320 |
| Market Cap | 20.892B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.87 |
| Earnings Date | Jan. 29, 2020 |
| Forward Dividend & Yield | 0.52 (1.87%) |
| Ex-Dividend Date | Nov. 25, 2019 |
| 1y Target Est | 30.65 |
- Simply Wall St.
Based On Its ROE, Is Corteva, Inc. (NYSE:CTVA) A High Quality Stock?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Zacks
Agriculture Operations Outlook: U.S. Corn Exports to be Feeble
Agriculture Operations Outlook: U.S. Corn Exports to be Feeble
- Bloomberg
DuPont’s Breakups Only Lead to More Breakups
(Bloomberg Opinion) -- Round and round the DuPont merry-go-round of financial engineering we go.The chemicals giant agreed on Sunday to sell its nutrition and biosciences division to International Flavors & Fragrances Inc. via a tax-friendly Reverse Morris Trust transaction that values the business at about $26 billion. DuPont de Nemours Inc. will receive a one-time $7.3 billion cash payment and its shareholders will own 55.4% of the combined entity.This is just the latest in a long line of dealmaking by DuPont chairman Ed Breen, who earned the respect of the investing world for salvaging Tyco International from scandal in part by breaking it up several times.(1) At DuPont, he’s helped orchestrate a complicated merger with rival Dow Chemical and a subsequent three-way split. After some rejiggering of the combined companies’ various assets amid pushback from activist investors, DuPont this year spun off the Dow Inc. commodity-chemical business and the Corteva Inc. agricultural-products company. Breen may not be done tinkering with DuPont’s portfolio after the International Flavors deal; Bloomberg News has reported that DuPont is also evaluating a divestiture of its transportation and industrial-chemicals unit. The results of all this maneuvering have been just so-so. Dow is up about 9% since the March record date for its separation, lagging the S&P 500 Index and the benchmark’s materials sub-group. Corteva has slumped nearly 6% since its May debut. DuPont itself is down more than 14% so far this year. That’s partly a reflection of the sheer amount of time it took to orchestrate this complicated musical chairs.The merger with Dow was announced four years ago, and the interim waiting period can create a sort of spin purgatory as investors hold off on rewarding a soon-to-be-simpler company with a valuation lift until all the paperwork is signed. And when a process takes that long, you’re bound to become a victim of bad timing. Dow and Corteva were spun off into a terrible market for chemicals as the U.S.-China trade war and a slowing economic backdrop weighed on demand and profit margins. Moody’s Investors Service this month issued its 2020 outlook for the North American and EMEA chemical sector, calling for an average Ebitda decline of about 5% amid soft commodity prices and weak investment trends. DuPont shares, meanwhile, also have been dragged down by its legal fight with a prior spinoff, Chemours Co., over liabilities linked to PFAS, the so-called forever chemical that was used in the manufacturing of Teflon.Breakup enthusiasts would tell you the share slump might have been worse if these businesses were still bundled together and one management team was trying to oversee their competing capital requirements and growth profiles. There’s certainly a logic to this latest deal. Nutrition and biosciences is DuPont’s largest division and has one of the more attractive growth profiles, but DuPont clearly wasn’t getting credit for this business in its stock.The deal with IFF values the DuPont unit at more than 18 times its adjusted Ebitda in the past year, according to data compiled by Bloomberg. That’s well above what the parent company commands. At the same time, there’s a reason the nutrition and biosciences unit commands a higher valuation. The removal of this generally stable business may make it harder for DuPont to prove that its earnings and sales growth can rise above economic volatility.If DuPont follows through on carving out the transportation and industrial unit as well, that would help limit its exposure to the swings in the automotive industry, which has been a particularly tough market of late. But it’s unclear what the endgame is here. There’s something deeply unsatisfying about a company using yet more breakups to fix a valuation disconnect that its first round of breakups was meant to rectify. Eventually, you run out of assets to sell or spin off. (1) Tyco eventually merged with Johnson Controls years after Breen had moved on, and the combined company took the latter’s name.To contact the author of this story: Brooke Sutherland at bsutherland7@bloomberg.netTo contact the editor responsible for this story: Beth Williams at bewilliams@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Brooke Sutherland is a Bloomberg Opinion columnist covering deals and industrial companies. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
- Zacks
Things to Know Ahead of Corteva's (CTVA) Q3 Earnings Release
Corteva's (CTVA) Q3 performance is likely to have been impacted by softness in North American market. However, the company is on track with cost saving initiatives.
- Simply Wall St.
Could Corteva, Inc.'s (NYSE:CTVA) Investor Composition Influence The Stock Price?
Every investor in Corteva, Inc. (NYSE:CTVA) should be aware of the most powerful shareholder groups. Insiders often...
- Morningstar
Market Too Focused on Corteva's Near Term
Since seed and crop chemical company Corteva CTVA was spun out of DowDuPont in June, we think the market has focused on near-term uncertainties like the effects of flooded U.S. fields and the dry start to the Brazilian planting season. If plantings pick up in October, the effect could be that sales simply shift from Corteva's third quarter to the fourth, similar to the delayed U.S. plantings in 2018. Regardless, we remain optimistic on Corteva's long-term outlook and view the shares as undervalued.
- Simply Wall St.
Should Corteva, Inc.’s (NYSE:CTVA) Weak Investment Returns Worry You?
Today we'll look at Corteva, Inc. (NYSE:CTVA) and reflect on its potential as an investment. Specifically, we're going...
- Zacks
Agriculture Operations Outlook: Tariffs to Mar Organic Gains
Agriculture Operations Outlook: Tariffs to Mar Organic Gains
- Motley Fool
After the DowDuPont Split: An Investor’s Guide to the 3 New Companies
The chemical industry heavyweight is gone, and DuPont and Dow are officially back -- but very different. Here's how to keep track of the new companies.
- Zacks
What Awaits Corteva (CTVA) in its Debut Q2 Earnings Report?
Digital efforts and product innovation are likely to benefit Corteva's (CVTA) second-quarter 2019 results. Further, it will gain from momentum in the seeds market.
- CNW Group
Corteva Completes Board of Directors with Appointment of Marcos Lutz
WILMINGTON, Del., June 26, 2019 /CNW/ -- Corteva, Inc. (NYSE: CTVA) announced today that Marcos Lutz, chief executive officer of Cosan Limited, has been elected to Corteva's Board of Directors, effective June 25, 2019. Greg Page, Non-Executive Chairman of Corteva and retired chairman and CEO of Cargill, Inc., said, "As we've built the Corteva Board, we've brought together a powerful team of experienced leaders with diverse expertise in strategic areas of focus. "The completion of our Board of Directors is a critical next step for Corteva.
- CNW Group
Corteva Announces $1 Billion Share Repurchase Program and Quarterly Dividend
WILMINGTON, Del., June 26, 2019 /CNW/ -- Corteva, Inc. (NYSE: CTVA) today announced the authorization of a $1 billion share repurchase program and first common stock dividend after its spinoff from DowDuPont – collectively reinforcing the Company's ongoing commitment to return value to shareholders. The Company's Board of Directors authorized a $1 billion share repurchase program. The program is expected to be completed in three years.
- CNW Group
Corteva Recommends Stockholders Reject Mini-Tender Offer by TRC Capital Corporation
WILMINGTON, Del., June 25, 2019 /CNW/ -- Corteva, Inc. (NYSE: CTVA) (www.corteva.com), a global leader in seed and crop protection, has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation ("TRC") to purchase up to 5,000,000 shares, or approximately 0.67 percent, of the outstanding common stock of Corteva at a price of $26.00 per share in cash. TRC's offer price is approximately 4.45 percent less than the $27.21 closing price of Corteva's common stock on June 21, 2019, the day before the mini-tender offer commenced, and is approximately 7.18 percent less than the $28.01 closing price of Corteva's common stock on June 24, 2019. Corteva does not endorse TRC's mini-tender offer and recommends that Corteva stockholders do not tender their shares in response to the offer because it is a mini-tender offer at a price below the market price for Corteva shares (as of the date Corteva received notice of the offer) and is subject to numerous conditions.
- Motley Fool
Better Buy: Scotts Miracle-Gro vs. Corteva Agriscience
These two companies operate in different parts of the global agriculture industry. Which is a better choice for investors today?
- Yahoo Finance
How consolidation in the seed industry is jeopardizing our future food supply
Dan Barber, co-founder of Row 7 Seed Company and chef and co-owner of the Blue Hill and Blue Hill at Stone Barns restaurants, highlights how consolidation in the agriculture space, in which four companies control the seed market, will pose a problem for the future of food.
- CNW Group
Corteva Agriscience™ Completes Separation from DowDuPont to Form Leading, Independent, Global Pure-Play Agriculture Company
WILMINGTON, Del., June 3, 2019 /CNW/ -- Corteva, Inc. (NYSE: CTVA) successfully completed its separation from DowDuPont, becoming a leading, global pure-play agriculture company that offers the complete solutions farmers need to maximize yield and profitability. Corteva Agriscience launches today with global scale and a balanced offering across seed and crop protection, underpinned by expanding digital capabilities and powered by the broadest and most productive innovation pipeline in the industry.
